Oct4 redox sensitivity potentiates reprogramming and differentiation

  1. Dean Tantin1,2
  1. 1Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA;
  2. 2Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA;
  3. 3Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA;
  4. 4Howard Hughes Medical Institute, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA;
  5. 5Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
  1. Corresponding author: dean.tantin{at}path.utah.edu
  1. 6 These authors contributed equally to this work.

Abstract

The transcription factor Oct4/Pou5f1 is a component of the regulatory circuitry governing pluripotency and is widely used to induce pluripotency from somatic cells. Here we used domain swapping and mutagenesis to study Oct4's reprogramming ability, identifying a redox-sensitive DNA binding domain, cysteine residue (Cys48), as a key determinant of reprogramming and differentiation. Oct4 Cys48 sensitizes the protein to oxidative inhibition of DNA binding activity and promotes oxidation-mediated protein ubiquitylation. Pou5f1C48S point mutation has little effect on undifferentiated embryonic stem cells (ESCs) but upon retinoic acid (RA) treatment causes retention of Oct4 expression, deregulated gene expression, and aberrant differentiation. Pou5f1C48S ESCs also form less differentiated teratomas and contribute poorly to adult somatic tissues. Finally, we describe Pou5f1C48S (Janky) mice, which in the homozygous condition are severely developmentally restricted after E4.5. Rare animals bypassing this restriction appear normal at birth but are sterile. Collectively, these findings uncover a novel Oct4 redox mechanism involved in both entry into and exit from pluripotency.

Keywords

Footnotes

  • Received December 4, 2023.
  • Accepted April 17, 2024.

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents

Life Science Alliance